Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma
{{output}}
"Pseudoprogression" following immune checkpoint inhibitors (ICI) in glioblastoma is often considered in case of radiographic progression. To better characterize the frequency of this phenomenon in glioblastoma, we reviewed the imaging response characteristic... ...